Growth Metrics

Glaukos (GKOS) Cash from Investing Activities Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Glaukos 6.00 Bn 5.90 Bn 117.23 Mn 128.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 128.43%
Dec 31, 2025 -234.81%
Sep 30, 2025 -113.06%
Jun 30, 2025 -159.61%
Mar 31, 2025 -25.75%
Dec 31, 2024 191.22%
Sep 30, 2024 105.16%
Jun 30, 2024 34.35%
Mar 31, 2024 -112.43%
Dec 31, 2023 -177.58%
Sep 30, 2023 -38.92%
Jun 30, 2023 169.48%
Mar 31, 2023 -134.56%
Dec 31, 2022 287.73%
Sep 30, 2022 193.58%
Jun 30, 2022 573.45%
Mar 31, 2022 72.27%
Dec 31, 2021 -156.49%
Sep 30, 2021 85.65%
Jun 30, 2021 90.16%
Mar 31, 2021 -3,485.83%
Dec 31, 2020 -106.94%
Sep 30, 2020 -4,356.60%
Jun 30, 2020 -3,350.25%
Mar 31, 2020 136.66%
Dec 31, 2019 380.60%
Sep 30, 2019 31.32%
Jun 30, 2019 -123.60%
Mar 31, 2019 67.40%
Dec 31, 2018 -130.85%
Sep 30, 2018 -311.09%
Jun 30, 2018 319.74%
Mar 31, 2018 -149.95%
Dec 31, 2017 -169.07%
Sep 30, 2017 85.81%
Jun 30, 2017 74.91%
Mar 31, 2017 75.23%
Dec 31, 2016 95.92%
Sep 30, 2016 -5,456.28%
Jun 30, 2016 -13,848.48%
Mar 31, 2016 -3,847.44%
Dec 31, 2015 -23,998.28%
Sep 30, 2015 -1,207.14%